Viracta Therapeutics Management
Management criteria checks 2/4
Viracta Therapeutics' El consejero delegado es Mark Rothera , nombrado en Sep 2022, tiene un mandato de 1.25 años. la remuneración anual total es $5.72M , compuesta por 2.9% salario y 97.1% primas, incluidas acciones y opciones de la empresa. posee directamente 0.26% de las acciones de la empresa, por valor de $50.18K . La antigüedad media del equipo directivo y del consejo de administración es de 2.6 años y 5.3 años respectivamente.
Key information
Mark Rothera
Chief executive officer
US$5.7m
Total compensation
| CEO salary percentage | 2.9% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.3% |
| Management average tenure | 2.8yrs |
| Board average tenure | 5.6yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$51m |
| Sep 30 2023 | n/a | n/a | -US$48m |
| Jun 30 2023 | n/a | n/a | -US$53m |
| Mar 31 2023 | n/a | n/a | -US$51m |
| Dec 31 2022 | US$6m | US$167k | -US$49m |
Compensación vs. Mercado: Mark($USD5.72M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD738.70K).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Mark con los resultados de la empresa.
CEO
Mark Rothera (60 yo)
1.6yrs
Tenure
US$5,720,657
Compensation
Mr. Mark Andrew Rothera serves as Chief Executive Officer, President & Director of Viracta Therapeutics, Inc. since September 19, 2022. He served as President, Chief Executive Officer and Executive Directo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.6yrs | US$5.72m | 0.25% $ 109.0k | |
| Scientific Founder and Consultant | 13.3yrs | no data | no data | |
| Co-Founder and Consultant | 13.3yrs | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Co-Founder | no data | no data | no data | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Senior VP | less than a year | no data | no data | |
| Chief Scientific Officer | 2.8yrs | no data | no data | |
| Senior VP of Legal Affairs & General Counsel | 2.2yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | 3.1yrs | no data | no data | |
| Senior Vice President of Business Development & Corporate Strategy | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
64yo
Average Age
Equipo directivo experimentado: VIRXEl equipo directivo de la empresa se considera experimentado (2.6 años de antigüedad media).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.6yrs | US$5.72m | 0.25% $ 109.0k | |
| Scientific Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Director | 16.5yrs | US$3.54m | 1.99% $ 853.1k | |
| Independent Director | 3.2yrs | US$158.70k | 0% $ 0 | |
| Member of Scientific Advisory Board | 5.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.6yrs | no data | no data | |
| Independent Director | 3.1yrs | US$156.20k | 0% $ 0 | |
| Independent Chairman of the Board | 3.8yrs | US$322.79k | 0.25% $ 108.3k | |
| Member of Scientific Advisory Board | 5.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.6yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.6yrs | no data | no data | |
| Independent Director | 3.1yrs | US$153.70k | 0% $ 0 |
5.6yrs
Average Tenure
66yo
Average Age
Junta con experiencia: La junta directiva de VIRX se considera experimentada (5.3 años de antigüedad promedio).